Gaetano Paone1, Robert Brewer2, Donald S Likosky3, Patricia F Theurer4, Gail F Bell4, Chad M Cogan2, Richard L Prager5. 1. Division of Cardiac Surgery, Henry Ford Hospital, Detroit, Michigan. Electronic address: gpaone1@hfhs.org. 2. Division of Cardiac Surgery, Henry Ford Hospital, Detroit, Michigan. 3. Section of Health Services Research and Quality, Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan. 4. Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, Ann Arbor, Michigan. 5. Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative, Ann Arbor, Michigan; Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.
Abstract
BACKGROUND: Between January 2008 and December 2012, a multicenter quality collaborative initiated a focus on blood conservation as a quality metric, with educational presentations and quarterly reporting of institutional-level perioperative transfusion rates and outcomes. This prospective cohort study was undertaken to determine the effect of that initiative on transfusion rates after isolated coronary artery bypass grafting (CABG). METHODS: Between January 1, 2008, and December 31, 2012, 30,271 patients underwent isolated CABG in Michigan. Evaluated were annual crude and adjusted trends in overall transfusion rates for red blood cells (RBCs), fresh frozen plasma (FFP), and platelets, and in operative death. RESULTS: Transfusion rates continuously decreased for all blood products. RBC use decreased from 56.4% in 2008 (baseline) to 38.3% in 2012, FFP use decreased from 14.8% to 9.1%, and platelet use decreased from 20.5% to 13.4% (ptrend < 0.001 for all). A significant reduction occurred in deep sternal wound infection, reoperation for bleeding, renal failure, prolonged ventilation, initial ventilator time, and intensive care unit duration. The percentage of patients discharged home significantly increased (ptrend < 0.001). Mortality rates did not differ significantly (ptrend = 0.11). CONCLUSIONS: In a multicenter quality collaborative, increased attention to transfusion-related outcomes and blood conservation techniques, coincident with regular reporting and review of perioperative transfusion rates as a quality metric, was associated with a significant decrease in blood product utilization. These reductions were concurrent with significant improvement in most perioperative outcomes. This intervention was also safe, as it was not associated with any increases in mortality.
BACKGROUND: Between January 2008 and December 2012, a multicenter quality collaborative initiated a focus on blood conservation as a quality metric, with educational presentations and quarterly reporting of institutional-level perioperative transfusion rates and outcomes. This prospective cohort study was undertaken to determine the effect of that initiative on transfusion rates after isolated coronary artery bypass grafting (CABG). METHODS: Between January 1, 2008, and December 31, 2012, 30,271 patients underwent isolated CABG in Michigan. Evaluated were annual crude and adjusted trends in overall transfusion rates for red blood cells (RBCs), fresh frozen plasma (FFP), and platelets, and in operative death. RESULTS: Transfusion rates continuously decreased for all blood products. RBC use decreased from 56.4% in 2008 (baseline) to 38.3% in 2012, FFP use decreased from 14.8% to 9.1%, and platelet use decreased from 20.5% to 13.4% (ptrend < 0.001 for all). A significant reduction occurred in deep sternal wound infection, reoperation for bleeding, renal failure, prolonged ventilation, initial ventilator time, and intensive care unit duration. The percentage of patients discharged home significantly increased (ptrend < 0.001). Mortality rates did not differ significantly (ptrend = 0.11). CONCLUSIONS: In a multicenter quality collaborative, increased attention to transfusion-related outcomes and blood conservation techniques, coincident with regular reporting and review of perioperative transfusion rates as a quality metric, was associated with a significant decrease in blood product utilization. These reductions were concurrent with significant improvement in most perioperative outcomes. This intervention was also safe, as it was not associated with any increases in mortality.
Authors: Donald S Likosky; Steven D Harrington; Lourdes Cabrera; Alphonse DeLucia; Carol E Chenoweth; Sarah L Krein; Dylan Thibault; Min Zhang; Roland A Matsouaka; Raymond J Strobel; Richard L Prager Journal: Circ Cardiovasc Qual Outcomes Date: 2018-11
Authors: Terry Shih; Min Zhang; Mallika Kommareddi; Theodore J Boeve; Steven D Harrington; Robert J Holmes; Gary Roth; Patricia F Theurer; Richard L Prager; Donald S Likosky Journal: Circ Cardiovasc Qual Outcomes Date: 2014-07-01
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Bix E Swain; Marla N Gardner; Patricia Kipnis; Darrell J Triulzi; Jerome L Gottschall; Yan Wu; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: Transfusion Date: 2014-08-18 Impact factor: 3.157
Authors: Donald S Likosky; Amelia S Wallace; Richard L Prager; Jeffrey P Jacobs; Min Zhang; Steven D Harrington; Paramita Saha-Chaudhuri; Patricia F Theurer; Astrid Fishstrom; Rachel S Dokholyan; David M Shahian; J Scott Rankin Journal: Ann Thorac Surg Date: 2015-08-28 Impact factor: 4.330
Authors: Nareg H Roubinian; Gabriel J Escobar; Vincent Liu; Marla N Gardner; Jeffrey L Carson; Steven H Kleinman; Edward L Murphy Journal: JAMA Intern Med Date: 2014-08 Impact factor: 21.873
Authors: Lesley J J Soril; Thomas W Noseworthy; Laura E Dowsett; Katherine Memedovich; Hannah M Holitzki; Diane L Lorenzetti; Henry Thomas Stelfox; David A Zygun; Fiona M Clement Journal: BMJ Open Date: 2018-05-18 Impact factor: 2.692
Authors: Alicia Chen; Amal N Trivedi; Lan Jiang; Michael Vezeridis; William G Henderson; Wen-Chih Wu Journal: Medicine (Baltimore) Date: 2015-08 Impact factor: 1.817